Jul 14, 2022
High-dose, once-daily thoracic radiotherapy (TRT) and standard twice daily TRT were well tolerated by patients with LS-SCLC, although many preferred the convenience of the once-a-day regimen. &....
Jun 01, 2022
Jun 01, 2022
Jun 01, 2022
More Meeting Coverage
Aug 10, 2022
Black/Hispanic patients with TP53 mutation (m) acute myeloid leukemia (AML) had worse overall survival (OS) compared with White patients, according to study results presented by Talha Badar, MBBS,....
Jun 17, 2022
May 24, 2022
May 23, 2022
May 05, 2022
Apr 25, 2022
Apr 04, 2022
Mar 07, 2022
Jan 08, 2022
Jan 07, 2022
Jan 05, 2022
Overall outcomes good after Covid infection, vaccine for most patients At the recent Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, several researchers shed light on how patients wit....
Dec 22, 2021
Dec 06, 2021
Jan 11, 2022
The ASOPRS 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly. The ASOPRS 2022 PhysQuiz was created by the editorial staff at Physician’s Weekly.....
Jan 06, 2022
Nov 19, 2021
Dec 14, 2021
Nov 30, 2021
Nov 02, 2021
Nov 02, 2021
Jul 29, 2021
Jul 01, 2021
Dec 17, 2021
Dec 02, 2021
Nov 08, 2021
Dec 30, 2021
Benefit driven by 29% relative reduction in heart failure hospitalization SGLT2 inhibitors were not the only treatments in 2021 showing cardiac benefit for patients with chronic kidney disease and ty....
Dec 09, 2021
Nov 11, 2021
Jan 03, 2022
Guidelines recommend biomarker testing, but is it done? Next-generation sequencing (NGS) may help increase biomarker testing rates in patients with metastatic NSCLC, but are clinicians taking advanta....
Aug 03, 2021
Jul 23, 2021
